A ‘Rule of Three’ for fragment-based lead discovery?

Hann, 2001, Molecular complexity and its impact on the probability of finding leads for drug discovery, J. Chem. Inf. Comput. Sci., 41, 856, 10.1021/ci000403i

Oprea, 2001, Is there a difference between leads and drugs? A historical perspective, J. Chem. Inf. Comput. Sci., 41, 1308, 10.1021/ci010366a

Owens, 2003, Chris Lipinski discusses life and chemistry after the Rule of Five, Drug Discov. Today, 8, 12, 10.1016/S1359-6446(02)02556-4

Lipinski, 2001, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Delivery Rev., 46, 3, 10.1016/S0169-409X(00)00129-0

Veber, 2002, Molecular Properties That Influence the Oral Bioavailability of Drug Candidates, J. Med. Chem., 45, 2615, 10.1021/jm020017n

Clark, 2000, Computational methods for the prediction of drug-likeness, Drug Discov. Today, 5, 49, 10.1016/S1359-6446(99)01451-8

Teague, 1999, The design of leadlike combinatorial libraries, Angwe. Chemie Int. Ed., 38, 3743, 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U

Carr, 2002, Structure-based screening of low-affinity compounds, Drug Discov. Today, 7, 522, 10.1016/S1359-6446(02)02245-6

Erlanson, 2000, Site-directed ligand discovery, Proc. Natl. Acad. Sci. U. S. A., 97, 9367, 10.1073/pnas.97.17.9367

Vetter, 2002, Chemical microarrays, fragment diversity, label-free imaging by plasmon resonance-a chemical genomics approach, J. Cell. Biochem., 39, 79, 10.1002/jcb.10408